100 search results
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
NewCochrane EvidencePublished 21 Jul 2017
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
What is the issue? Calcineurin inhibitors (CNI, cyclosporin and tacrolimus) are an important part of treatment to suppress the immune system to prevent rejection of transplanted kidneys. However, CNI can cause high blood pressure and kidney scarring which contribute to worsening of risk factors for heart attack, stroke, and loss of the transplanted ... -
NewCochrane EvidencePublished 21 Jul 2017
Histologic measurement tools for evaluation of disease activity in Crohn’s disease
What is Crohn's disease? Crohn’s disease is a life-long (chronic), inflammatory disease of the gastrointestinal tract characterized by abdominal pain (cramping), rectal bleeding, diarrhoea, weight loss, and tiredness. The disease has a changing course with periods of symptoms (called 'active' disease or relapse) and periods without symptoms (called ... -
NewCochrane EvidencePublished 21 Jul 2017
Antibiotics for induction and maintenance of remission in Crohn's disease
Protocol: To determine whether antibiotic therapy is safe and effective for induction or maintenance of remission in CD. -
NewCochrane EvidencePublished 20 Jul 2017
Prebiotics for the prevention of hyperbilirubinaemia in neonates
Protocol: To determine whether administration of prebiotics reduces the incidence of hyperbilirubinaemia among term and preterm infants compared with enteral supplementation of milk with distilled water or no supplementation. -
NewCochrane EvidencePublished 20 Jul 2017
Haloperidol versus risperidone for schizophrenia
Protocol: To review the clinical effectiveness and safety of haloperidol compared with risperidone for people with schizophrenia. -
NewCochrane EvidencePublished 20 Jul 2017
Which airway device (ProSeal or Classic laryngeal airway mask) provides more effective artificial breathing during anaesthesia for adults?
Review question We wanted to find out if one type of artificial breathing device used in adults during anaesthesia is more effective and safer than another. Background Patients anaesthetized for surgical procedures often need to be put on artificial breathing machines (ventilators) to help their breathing. This involves putting into the patient's ... -
NewCochrane EvidencePublished 20 Jul 2017
Head midline (central) position for preventing intraventricular hemorrhage (i.e., bleeding in the brain) in very preterm infants
Review question: Does head midline position reduce the risk of intraventricular hemorrhage (i.e., bleeding in the brain) and mortality in very preterm infants? Background: Intraventricular hemorrhage (i.e., bleeding in the brain) occurs in 25% of very low birth weight infants and may be caused by multiple factors. Head position may affect how the ... -
NewCochrane EvidencePublished 19 Jul 2017
Opioids for cancer-related pain in children and adolescents
Bottom line There is no evidence from randomised controlled trials to support or contradict the suggestion that opioids in any dose will reduce cancer-related pain in children or adolescents. Background Childhood cancer is one of the leading causes of disease and death for children and adolescents in the world today. Its associated pain is a ... -
NewCochrane EvidencePublished 17 Jul 2017
[Interventions to aid employment for people on dialysis]
Protocol: To evaluate the effectiveness of interventions aimed at assisting employment for people on dialysis, or their family caregivers. -
NewCochrane EvidencePublished 17 Jul 2017
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
Protocol: To evaluate the safety and efficacy of beta-blockers (BBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor antagonists (ARBs), mineralocorticoid receptor antagonists (MRAs), and angiotensin receptor neprilysin inhibitors (ARNIs) for the treatment of patients with heart failure (HF) with preserved ejection fraction ...
